DGAP-News: CannaVest Corp. and US Hemp Oil Featured on FOX

DGAP-News: CannaVest Corp. / CannaVest Corp. and US Hemp Oil Featured on FOX 5 News 28.02.2014 / 15:00 --------------------------------------------------------------------- U.S. Hemp Pioneer, Chris Boucher, Comments on Domestic 'Agro-Economic Explosion;' John Hicks III, MD Shares Medical Opinion on Industrial Hemp-Based CBD SAN DIEGO, 2014-02-28 15:00 CET (GLOBE NEWSWIRE) -- CannaVest Corp. (OTC:CANV), the world's leading hemp-based investment company spearheading the development of cannabidiol (CBD)-rich hemp oils and other hemp industry-related products and services, recently was featured by Fox 5 News in San Diego. Fox 5 reporter Heather Ford's feature story, 'Healing with Hemp,' included U.S. hemp industry pioneer and Vice President of Product Development for CannaVest, Chris Boucher, and integrative physician John Hicks III, MD. Mr. Boucher is the first to have legally planted a domestic hemp field in America in over forty years at the United States Department of Agriculture (USDA) Research Center in Imperial County, California. 2014 marks the twentieth anniversary of the planting of his hemp field. Mr. Boucher states in the Fox 5 News interview that with the passing of the Agricultural Act of 2014, commonly known as the 'Farm Bill,' there will be an 'agro-economic explosion.' He goes on to state that, 'As the public becomes more educated on hemp, more people are going to want to use it.' The Fox 5 News story also featured Dr. John Hicks III, MD, who opined that research on CBD demonstrates that it can control ailments ranging from seizures to eczema. Dr. Hicks addressed Heather Ford's question about the difference between marijuana and hemp, and explained that hemp-based CBD cannot get anyone 'high.' Fox 5 News anchor, Raoul Martinez, states at the end of the 'Healing with Hemp' feature, 'There's been a lot of negative connotations [about hemp], and I think we're clearing that up.' CannaVest's subsidiary, PhytoSPHERE Systems, adheres to a strict quality control process when producing the world's highest quality and most concentrated CBD-rich industrial hemp oil. All of the Company's products undergo multiple internal quality control checks and are submitted to independent labs for analysis throughout the manufacturing process. This ensures industry-leading consistency that consumers demand worldwide. PhytoSPHERE Systems is internationally recognized for producing the world's first and most concentrated form of CBD from industrial hemp. Most recently, the Company took top honors at the 2014 Los Angeles High Times Medical Cannabis Cup for the Highest CBD Concentrate with their CBD-rich hemp oil prototype, CBD Simple(tm). CBD Simple(tm) is not available for public purchase, but is intended for future product development. The 2014 Los Angeles High Times Medical Cannabis Cup was the fourth award competition that PhytoSPHERE and CannaVest won for producing the highest concentration of CBD from hemp. CBD Simple(tm) also won the 2013 High Times Cannabis Cup competition in Amsterdam, the 2013 Seattle High Times Cannabis Cup, and the 2013 Michigan Medical Marijuana Conference 'Green Cup' contest--all for Highest CBD Concentrate. In addition to CBD Simple(tm), PhytoSPHERE is responsible for developing CBD-rich hemp oil products including Real Scientific Hemp Oil (RSHO)(tm), the highest quality, all-natural, super concentrated CBD nutritional supplement on the market today; Cibdex(tm), an everyday CBD-rich hemp oil supplement available in 100mg and 500mg tinctures and 25mg vegan capsules; and Cibaderm(tm), a CBD-rich hemp oil infused personal care line that includes first-of-its-kind hair care, body care, lotions and salve. All three product lines were featured by Fox 5 News. The Company's CBD-rich hemp oil products are available through HempMedsPX(tm). For additional product information, please visit: HempMedsPX(tm) http://www.HempMedsPX.com 866.273.8502 Real Scientific Hemp Oil(tm) http://RealScientificHempOil.com 866.273.8502 Cibdex(tm) http://www.cibdex.com 866.273.8502 Cibaderm(tm) http://www.cibaderm.com 866.273.8502 About CannaVest Corp. CannaVest Corp. is in the business of investing and developing hemp-based businesses. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells--to third parties--raw product acquired by CannaVest Corp. pursuant to the company's supply international relationships. CannaVest seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com. About PhytoSPHERE Systems, LLC PhytoSphere Systems is a global phytocannabinoid biotechnology company based in San Diego, California and a wholly-owned subsidiary of CannaVest Corp. (OTC:CANV). The company utilizes advanced cultivation methods and state-of-the-art processing technology leading to development of pharmaceutical, nutraceutical and food products. PhytoSphere Systems, the manufacturer of the CBD-rich hemp oil used in Real Scientific Hemp Oil (RSHO), has developed special cultivars (similar to 'strains') that produce hemp that is especially rich in CBD, making it possible for PhytoSPHERE to offer all-natural products with high concentrations of hemp-based CBD. For more information, visit: PhytoSphereSystems.com About HempMedsPX, Inc. HempMedsPX(tm), Inc. offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies. FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein. LEGAL DISCLOSURE CannaVest Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil. CONTACT: Corporate Contact: CannaVest Corp. 2688 South Rainbow Avenue, Suite B Las Vegas, NV 89146 Phone: 866-290-2157 www.cannavest.com News Source: NASDAQ OMX End of Corporate News --------------------------------------------------------------------- 28.02.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: CannaVest Corp. United States ISIN: US1376531018 End of News DGAP News-Service --------------------------------------------------------------------- 255161 28.02.2014